COMPASS Pathways' COMP360: A Game-Changer for Treatment-Resistant Depression episode artwork

EPISODE · May 13, 2026 · 2 MIN

COMPASS Pathways' COMP360: A Game-Changer for Treatment-Resistant Depression

from The Daily News Now! Business

COMPASS Pathways has reported positive phase three trial results for their psychedelic therapy COMP360, treating treatment-resistant depression. Theyre submitting a new drug application to the FDA, aiming for approval by year-end. With a Commissioners National Priority Voucher and potential DEA rescheduling, COMP360 could become a blockbuster drug, reducing healthcare costs for the four million affected individuals. Theyre also advancing PTSD trials and have a strong cash runway. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/c0382854958e1592

NOW PLAYING

COMPASS Pathways' COMP360: A Game-Changer for Treatment-Resistant Depression

0:00 2:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 2 minutes long.

When was this The Daily News Now! Business episode published?

This episode was published on May 13, 2026.

What is this episode about?

COMPASS Pathways has reported positive phase three trial results for their psychedelic therapy COMP360, treating treatment-resistant depression. Theyre submitting a new drug application to the FDA, aiming for approval by year-end. With a...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!